NO20054835L - Fremgangsmate for fremstilling av krystallinsk ciclesonid med definert partikkelstorrelse - Google Patents

Fremgangsmate for fremstilling av krystallinsk ciclesonid med definert partikkelstorrelse

Info

Publication number
NO20054835L
NO20054835L NO20054835A NO20054835A NO20054835L NO 20054835 L NO20054835 L NO 20054835L NO 20054835 A NO20054835 A NO 20054835A NO 20054835 A NO20054835 A NO 20054835A NO 20054835 L NO20054835 L NO 20054835L
Authority
NO
Norway
Prior art keywords
preparation
particle size
crystalline
defined particle
ciciesonide
Prior art date
Application number
NO20054835A
Other languages
English (en)
Other versions
NO331984B1 (no
Inventor
Klaus Eistetter
Ernst Sturm
Stefan Kaupp
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054835(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of NO20054835L publication Critical patent/NO20054835L/no
Publication of NO331984B1 publication Critical patent/NO331984B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen vedrører en ny fremgangsmåte for fremstilling av krystallinsk ciciesonid med en fordelaktig partikkelstørrelse og anvendelsen for å produsere farmasøytiske preparater, spesielt for topisk anvendelse. Det krystallinske ciciesonid oppnådd ved den nye fremgangsmåte har fordelaktige aerodynamiske egenskaper, og kan bearbeides videre til inhalerbare eUer nasalt adminisfrerte farmasøytiske preparater uten ytterhgere mekanisk mikronisering.
NO20054835A 2003-03-27 2005-10-19 Krystallinsk ciclesonid med definert partikkelstørrelse, fremgangsmåte for fremstilling av det samme og farmasøytisk sammensetning omfattende det samme NO331984B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03007007 2003-03-27
DE10314097 2003-03-27
PCT/EP2004/050373 WO2004085460A1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size

Publications (2)

Publication Number Publication Date
NO20054835L true NO20054835L (no) 2005-10-19
NO331984B1 NO331984B1 (no) 2012-05-21

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054835A NO331984B1 (no) 2003-03-27 2005-10-19 Krystallinsk ciclesonid med definert partikkelstørrelse, fremgangsmåte for fremstilling av det samme og farmasøytisk sammensetning omfattende det samme

Country Status (28)

Country Link
US (1) US9422327B2 (no)
EP (1) EP1611150B1 (no)
JP (1) JP4746535B2 (no)
KR (1) KR101102709B1 (no)
AR (1) AR043579A1 (no)
AT (1) ATE546459T1 (no)
AU (1) AU2004224092B2 (no)
BR (1) BRPI0408569B1 (no)
CA (1) CA2519752C (no)
CL (1) CL2004000636A1 (no)
CY (1) CY1112970T1 (no)
DK (1) DK1611150T3 (no)
EA (1) EA011157B1 (no)
ES (1) ES2382928T3 (no)
HK (1) HK1088905A1 (no)
HR (1) HRP20050917B1 (no)
IL (1) IL170746A (no)
MX (1) MXPA05010041A (no)
MY (1) MY143936A (no)
NO (1) NO331984B1 (no)
NZ (1) NZ542827A (no)
PE (1) PE20050388A1 (no)
PL (1) PL1611150T3 (no)
PT (1) PT1611150E (no)
RS (1) RS52549B (no)
SI (1) SI1611150T1 (no)
TW (1) TWI328589B (no)
WO (1) WO2004085460A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2622640A1 (en) * 2005-11-02 2007-05-18 Sicor Inc. Improved process for the preparation of ciclesonide
EP1904514A2 (en) * 2006-02-08 2008-04-02 Sicor, Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
WO2008035066A2 (en) * 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
CA2714653A1 (en) * 2008-03-13 2009-09-17 Farmabios S.P.A. Process for the preparation of pregnane derivatives
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
US20100120733A1 (en) * 2008-11-07 2010-05-13 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
US20150224197A1 (en) 2012-07-05 2015-08-13 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation compositions
WO2014007770A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
CA3025377A1 (en) 2016-06-02 2017-12-07 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
RU2020117698A (ru) 2017-12-01 2022-01-04 Эббви Инк. Агонист глюкокортикоидного рецептора и его иммуноконъюгаты

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
WO1990003782A2 (en) 1988-10-05 1990-04-19 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE69012458T3 (de) 1989-05-31 2000-01-20 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
AU683463B2 (en) 1993-04-02 1997-11-13 Astrazeneca Ab New prednisolone derivates
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
EP0749438B1 (de) 1994-03-09 2000-12-13 Byk Gulden Lomberg Chemische Fabrik GmbH Neue silylverbindungen und ihre verwendung
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
CA2376818A1 (en) 1999-06-25 2001-01-04 Cognis Deutschland Gmbh & Co. Kg Use of nanoscale sterols and sterol esters
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US7468433B2 (en) 2000-11-10 2008-12-23 Nycomed Gmbh Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation

Also Published As

Publication number Publication date
EP1611150B1 (en) 2012-02-22
AU2004224092A1 (en) 2004-10-07
DK1611150T3 (da) 2012-05-14
NO331984B1 (no) 2012-05-21
ATE546459T1 (de) 2012-03-15
WO2004085460A1 (en) 2004-10-07
WO2004085460A8 (en) 2007-03-15
CL2004000636A1 (es) 2005-02-04
US9422327B2 (en) 2016-08-23
PL1611150T3 (pl) 2012-07-31
ES2382928T3 (es) 2012-06-14
EA200501391A1 (ru) 2006-06-30
RS52549B (en) 2013-04-30
HRP20050917A2 (en) 2006-12-31
PE20050388A1 (es) 2005-05-30
BRPI0408569B1 (pt) 2017-08-29
RS20050704A (en) 2007-06-04
BRPI0408569A (pt) 2006-03-21
MXPA05010041A (es) 2005-11-17
HRP20050917B1 (hr) 2014-02-14
EP1611150A1 (en) 2006-01-04
CY1112970T1 (el) 2016-04-13
IL170746A0 (en) 2009-02-11
TW200418519A (en) 2004-10-01
PT1611150E (pt) 2012-05-07
AU2004224092B2 (en) 2010-03-04
AR043579A1 (es) 2005-08-03
KR20050114250A (ko) 2005-12-05
CA2519752C (en) 2012-05-29
JP4746535B2 (ja) 2011-08-10
IL170746A (en) 2012-06-28
SI1611150T1 (sl) 2012-06-29
NZ542827A (en) 2008-02-29
JP2006521332A (ja) 2006-09-21
KR101102709B1 (ko) 2012-01-05
CA2519752A1 (en) 2004-10-07
HK1088905A1 (en) 2006-11-17
MY143936A (en) 2011-07-29
US20060128954A1 (en) 2006-06-15
EA011157B1 (ru) 2009-02-27
TWI328589B (en) 2010-08-11

Similar Documents

Publication Publication Date Title
NO20054835L (no) Fremgangsmate for fremstilling av krystallinsk ciclesonid med definert partikkelstorrelse
WO2019191092A8 (en) Compounds for treating huntington's disease
WO2018226622A8 (en) Compounds for treating huntington's disease
NO20055219L (no) Nye forbindelser
NO20050917L (no) Thiomolybdatanaloger og anvendelser derav
MX363265B (es) Forma cristalina i de ibrutinib.
WO2007061661A4 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20063518L (no) Ny krystallinsk form IV av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20033181L (no) Substituerte alkylaminderivater og fremgangsmåter for anvendelse
WO2007054279A3 (en) Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
MXPA05010055A (es) Derivados de 2-fenoxi- y 2-fenil-sulfomamida con actividad antagonista del ccr3, para el tratamiento del asma y otros desordenes inflamatorios o inmunologicos.
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
WO2008125120A3 (en) Extract of trigonella foenum-graecum
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2011029547A3 (en) Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents
WO2006098006A1 (ja) 抗炎症剤
EP2816034A3 (en) Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
WO2005046569A3 (en) Pharmaceutical compositions for the treatment of sars
WO2007059931A8 (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
WO2003018568A3 (en) Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
RU2005140097A (ru) Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний
WO2007031334A3 (en) Vaccines comprising truncated hbc core protein plus saponin-based adjuvants
NO20061290L (no) Nye forbindelser

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA B.V., CH

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA GMBH, CH